These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 11986942)
1. Dexrazoxane has no impact on sensitivity of childhood leukemic blasts to daunorubicin. Styczynski J; Wysocki M; Balwierz W; Kowalczyk JR Leukemia; 2002 May; 16(5):820-5. PubMed ID: 11986942 [TBL] [Abstract][Full Text] [Related]
2. Resistance to daunorubicin-induced apoptosis is not completely reversed in CML blast cells by STI571. Tabrizi R; Mahon FX; Cony Makhoul P; Lagarde V; Lacombe F; Berthaud P; Melo JV; Reiffers J; Belloc F Leukemia; 2002 Jun; 16(6):1154-9. PubMed ID: 12040447 [TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells. Hu XM; Hirano T; Oka K Cancer Chemother Pharmacol; 2003 Feb; 51(2):119-26. PubMed ID: 12647012 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of dexrazoxane as a cardioprotective agent in patients receiving mitoxantrone- and daunorubicin-based chemotherapy. Lemez P; Maresová J Semin Oncol; 1998 Aug; 25(4 Suppl 10):61-5. PubMed ID: 9768826 [TBL] [Abstract][Full Text] [Related]
5. [The relationship between cytochrome P450, subfamily IIIA, polypeptide 5 gene and drug resistance in leukemia cell lines]. Wang T; Chen FY; Han JY; Zhong JH; Teng Y; Ouyang RR Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):527-9. PubMed ID: 15312409 [TBL] [Abstract][Full Text] [Related]
6. miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2. Li H; Hui L; Xu W Acta Biochim Biophys Sin (Shanghai); 2012 Mar; 44(3):269-77. PubMed ID: 22285729 [TBL] [Abstract][Full Text] [Related]
7. [Effect of daunorubicin and cytarabine on cell line NB4]. Luo ZG; Zhong L; Chen FY; Wang HR; Ouyang RR Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):247-9. PubMed ID: 17877202 [TBL] [Abstract][Full Text] [Related]
8. Effects of daunorubicin on cell growth, cell cycle and induction of apoptosis in HL-60 cells. Chikayama S; Kimura S; Kobayashi Y; Abe T; Maekawa T; Kondo M Haematologia (Budap); 1998; 29(2):115-21. PubMed ID: 9728803 [TBL] [Abstract][Full Text] [Related]
9. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines. Bailly JD; Muller C; Jaffrézou JP; Demur C; Gassar G; Bordier C; Laurent G Leukemia; 1995 May; 9(5):799-807. PubMed ID: 7769842 [TBL] [Abstract][Full Text] [Related]
10. [Restorative effect of quercetin on subcellular distribution of daunorubicin in multidrug resistant leukemia cell lines K562/ADM and HL-60/ADM]. Cai X; Chen FY; Han JY; Gu CH; Zhong H; Ouyang RR Ai Zheng; 2004 Dec; 23(12):1611-5. PubMed ID: 15601547 [TBL] [Abstract][Full Text] [Related]
11. Daunorubicin-induced internucleosomal DNA fragmentation in acute myeloid cell lines. Quillet-Mary A; Mansat V; Duchayne E; Come MG; Allouche M; Bailly JD; Bordier C; Laurent G Leukemia; 1996 Mar; 10(3):417-25. PubMed ID: 8642856 [TBL] [Abstract][Full Text] [Related]
12. Relationship between daunorubicin concentration and apoptosis induction in leukemic cells. Masquelier M; Zhou QF; Gruber A; Vitols S Biochem Pharmacol; 2004 Mar; 67(6):1047-56. PubMed ID: 15006541 [TBL] [Abstract][Full Text] [Related]
13. In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubicin in untreated childhood acute leukemia. Kaspers GL; Veerman AJ; Pieters R; van Zantwijk I; Klumper E; Hählen K; de Waal FC; van Wering ER Leukemia; 1994 Jan; 8(1):24-9. PubMed ID: 8289494 [TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3. Hu XM; Hirano T; Oka K Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841 [TBL] [Abstract][Full Text] [Related]
15. Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance. Lotfi K; Zackrisson AL; Peterson C Cancer Lett; 2002 Apr; 178(2):141-9. PubMed ID: 11867198 [TBL] [Abstract][Full Text] [Related]
16. Drastic effect of cell density on the cytotoxicity of daunorubicin and cytosine arabinoside. Masquelier M; Vitols S Biochem Pharmacol; 2004 May; 67(9):1639-46. PubMed ID: 15081863 [TBL] [Abstract][Full Text] [Related]
17. Daunorubicin-induced cell kill with 1-hour versus 24-hour infusions: a randomized comparison in children with newly diagnosed acute lymphoblastic leukemia. Escherich G; Göbel U; Jorch N; Spaar HJ; Janka-Schaub GE Klin Padiatr; 2007; 219(3):134-8. PubMed ID: 17525906 [TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemic cell lines. Zheng B; Zhou R; Gong Y; Yang X; Shan Q Int J Lab Hematol; 2012 Jun; 34(3):237-47. PubMed ID: 22145750 [TBL] [Abstract][Full Text] [Related]
19. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
20. [Effects of bortezomib combined with daunorubicin on proliferation and apoptosis in primary adult acute leukemia]. Zhou RQ; Gong YP; Zheng BH; Yang X Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):789-92. PubMed ID: 21302442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]